The chemical class known as Dynlt1d Inhibitors encompasses a series of compounds specifically designed to inhibit the activity of the Dynlt1d protein. Dynlt1d, identified through rigorous molecular biology and genetic research, is a protein that plays a crucial role in various cellular processes. The function of Dynlt1d is particularly important in cellular mechanisms and is subject to change based on the cellular environment and external stimuli. Inhibitors targeting Dynlt1d are developed with a focus on selective binding to this protein, thereby modulating its biological activity. The binding of these inhibitors to Dynlt1d is a key functional aspect, as it directly impacts the biochemical pathways in which Dynlt1d is involved. The primary goal of these inhibitors is to influence the activity of Dynlt1d, thereby affecting the related cellular processes and mechanisms.
The development of Dynlt1d Inhibitors is a complex and multifaceted task, involving the integration of molecular biology, chemistry, and structural biology. The process begins with a comprehensive understanding of the structure and functional dynamics of the Dynlt1d protein. Advanced techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational molecular modeling are utilized to gain a detailed perspective of the target protein. This foundational knowledge is essential for the rational design of inhibitors that are both effective in their interaction and highly selective for their target. These inhibitors are typically small molecules, optimized to penetrate cellular membranes efficiently and to establish a stable and potent interaction with Dynlt1d. The molecular design of these inhibitors is carefully refined to ensure a robust interaction with the target protein, typically involving the formation of hydrogen bonds, hydrophobic interactions, and van der Waals forces. The effectiveness of these inhibitors is evaluated through various biochemical assays in vitro. These assays are critical for determining the inhibitors' ability to inhibit the activity of Dynlt1d, assessing factors such as potency, specificity, and overall interaction dynamics. These studies provide essential insights into the behavior of the inhibitors, laying the groundwork for further research into their mechanism of action and interaction dynamics within cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylases, which may lead to changes in chromatin structure and reduced gene transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A cytidine analog that incorporates into DNA and RNA, leading to DNA demethylation and potentially affecting gene expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
A DNA methyltransferase inhibitor, potentially preventing the methylation of gene promoters and facilitating gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A deoxycytidine analog that inhibits DNA methyltransferase, potentially leading to hypomethylation of DNA and changes in gene expression. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A histone deacetylase inhibitor, which can alter the acetylation state of histones and affect gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor that may result in altered chromatin structure and modulation of gene expression. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
A selective inhibitor of histone deacetylases, potentially leading to transcriptional activation or repression of certain genes. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
A class I selective histone deacetylase inhibitor that may influence chromatin structure and gene expression. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
A potent pan-deacetylase inhibitor, affecting acetylation levels of histones and non-histone proteins, possibly altering gene expression profiles. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
A cyclic peptide that inhibits histone deacetylases, impacting gene expression by changing chromatin conformation. | ||||||